Results 111 to 120 of about 3,045,581 (181)

Linear IgA bullous dermatosis with Koebner phenomenon in a liver transplant patient. [PDF]

Postepy Dermatol Alergol, 2022
Ptak B, Knosala E, Wąsik G, Białynicki-Birula R, Baran W, Batycka-Baran A.   +5 more
europepmc   +1 more source

Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine. [PDF]

J Cutan Pathol, 2023
Nahm WJ, Juarez M, Wu J, Kim RH.
europepmc   +1 more source

Mogamulizumab-Induced Linear IgA Bullous Dermatosis in a Patient With Sézary Syndrome. [PDF]

Australas J Dermatol
Zulaika-Lloret M, Moyano-Bueno D, Ruiz-Villaverde R.   +2 more
europepmc   +1 more source

Linear IgA Bullous Dermatosis: A Rare Immune-Related Cutaneous Adverse Event Due to Pembrolizumab. [PDF]

Cureus
Motwani L, Doddapaneni VK, Heuring EL.
europepmc   +1 more source

Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine. [PDF]

Clin Exp Dermatol, 2022
Hali F, Kerouach A, Alatawna H, Chiheb S, Lakhdar H.   +4 more
europepmc   +1 more source

A case of anti-laminin 332-type mucous membrane pemphigoid mimicking linear IgA bullous dermatosis. [PDF]

JAAD Case Rep
Du X, Dang J, Zhao J, Shang P.
europepmc   +1 more source

Mucosal linear IgA disease with esophageal involvement responsive to ustekinumab

JAAD Case Reports, 2021
Amber Jimenez, BS, Christina Topham, MD, Danny Varedi, MD, Kristin M. Leiferman, MD, Christopher Hull, MD   +4 more
doaj   +1 more source

Vancomycin-induced linear IgA bullous dermatosis mimicking Stevens-Johnson syndrome/toxic epidermal necrolysis treated with etanercept. [PDF]

JAAD Case Rep
Alanazi R, Aldahash R, Alanazi SK, Almasoud SH, Alumair NA, Alghamdi W, Alhumidi A.   +6 more
europepmc   +1 more source

A case of linear IgA bullous dermatosis in a glucose-6-phosphate dehydrogenase-deficient child successfully treated with oral erythromycin and topical tacrolimus. [PDF]

JAAD Case Rep, 2023
Ramos MA, Cruz-Regalado JM, Bernales-Mendoza AM, Ramilo V.   +3 more
europepmc   +1 more source

Linear IgA Bullous Dermatosis in an Elderly Patient Following Meloxicam and Candesartan Use: A Case Report. [PDF]

Cureus
Albyali S, Alhedaithi N, Alqahtani R, Alenazi R, Alsharif F, Alhumidi A, Alkhamees S.   +6 more
europepmc   +1 more source